Vir Biotechnology, Inc. ( VIR) - Key Metrics
VIR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.42 | $0.48 | -$0.05 | -$0.06 |
| 2026Q1 | $0 | -$0.85 | -$0.90 | -$0.90 |
| 2025Q4 | $0.46 | -$0.31 | -$0.19 | -$0.15 |
| 2025Q3 | $0 | -$1.17 | -$1.21 | -$1.21 |
| 2025Q2 | $0.01 | -$0.80 | -$0.87 | -$0.89 |
VIR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 5.31 |
| 2026Q1 | 0% | -2.64 |
| 2025Q4 | 0% | -4.86 |
| 2025Q3 | 0% | -1.22 |
| 2025Q2 | 0% | -1.58 |
VIR
Price: $9.39
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 703157
Market Capitalization: 1.5 billion